---
layout: post
title: "Methodological Challenges Related to Patient Experience Data; Summary of Received Comments"
date: 2026-02-05 18:57:54 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-27312
original_published: 2023-12-13 00:00:00 +0000
significance: 8.00
---

# Methodological Challenges Related to Patient Experience Data; Summary of Received Comments

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** December 13, 2023 00:00 UTC
**Document Number:** 2023-27312

## Summary

The Food and Drug Administration (FDA) is announcing the availability of a summary on the comments received for the "Methodological Challenges Related to Patient Experience Data; Request for Information and Comments" notice published on May 2, 2023. The input received in response to the Request for Information will help FDA plan two public workshops focused on methodological challenges and will help FDA identify priorities for future work.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/12/13/2023-27312/methodological-challenges-related-to-patient-experience-data-summary-of-received-comments)
- API: https://www.federalregister.gov/api/v1/documents/2023-27312

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
